Brand-name drug
Eliquis price, strengths & recalls
Brand of apixaban (generic)
Pharmacies pay $165.64 for 30 tablets of Eliquis 5 mg tablet this week, and from $165.37 to $407.52 across its 3 priced strengths and forms. It has 1 recall on record, none ongoing. Its official label last changed on November 12, 2026.
Medicare price 2026Brand- Fair cash price
- $200.99
- Strengths
- 3
- Makers
- 1
- Updated
- Nov 11
Eliquis price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 30-day starter pack Brand | $5.51 | $407.52 / 74 tablets |
| 2.5 mg tablet Brand | $5.51 | $165.37 / 30 tablets |
| 5 mg tablet Brand | $5.52 | $165.64 / 30 tablets |
The lowest cost per tablet is 30-day starter pack at $5.51. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.
Eliquis vs generic apixaban
There is no generic version of Eliquis on the market yet. Its last listed patent or exclusivity runs to August 24, 2031 - generics often follow, though court cases and settlements can move the date either way.
GenericApixaban pricesMedicare negotiated price
Medicare negotiated a maximum fair price of $231.00 for a 30-day supply of Eliquis, against a 2023 list price of $521.00. It has applied since January 1, 2026.
What this means for patients
- The negotiated price is what Medicare Part D plans pay for the drug - not your price at the counter.
- What you pay depends on your plan's copay or coinsurance and where you are in the year. Coinsurance (a percentage) falls with the price; a flat copay may not change at all.
- Out-of-pocket costs for Part D drugs are capped each year ($2,100 in 2026), whatever the drug.
- If you don't have Medicare, the negotiated price doesn't apply to you - check the fair cash price above instead.
Supply status: shortages & recalls
Recalls
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Eliquis
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use ELIQUIS safely and effectively. See full prescribing information for ELIQUIS.ELIQUIS® (apixaban) tablets, for oral useELIQUIS® (apixaban) tablets for oral suspensionELIQUIS® SPRINKLE (apixaban) for oral suspensionInitial U.S. Approval: 2012
WARNING: (A) PREMATURE DISCONTINUATION OF ELIQUIS INCREASES THE RISK OF THROMBOTIC EVENTS
(B) SPINAL/EPIDURAL HEMATOMA
(A) PREMATURE DISCONTINUATION OF ELIQUIS INCREASES THE RISK OF THROMBOTIC EVENTS
Premature discontinuation of any oral anticoagulant, including ELIQUIS, increases the risk of thrombotic events. If anticoagulation with ELIQUIS is discontinued for a reason other than pathological bleeding or completion of a course of therapy, consider coverage with another anticoagulant [see Dosage and Administration (2.5), Warnings and Precautions (5.1), and Clinical Studies (14.1)].
(B) SPINAL/EPIDURAL HEMATOMA
Epidural or spinal hematomas may occur in patients treated with ELIQUIS who are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures. Factors that can increase the risk of developing epidural or spinal hematomas in these patients include:
•
use of indwelling epidural catheters
•
concomitant use of other drugs that affect hemostasis, such as nonsteroidal anti-inflammatory drugs (NSAIDs), platelet inhibitors, other anticoagulants
•
a history of traumatic or repeated epidural or spinal punctures
•
a history of spinal deformity or spinal surgery
•
optimal timing between the administration of ELIQUIS and neuraxial procedures is not known
[see Warnings and Precautions (5.3)]
Monitor patients frequently for signs and symptoms of neurological impairment. If neurological compromise is noted, urgent treatment is necessary [see Warnings and Precautions (5.3)].
Consider the benefits and risks before neuraxial intervention in patients anticoagulated or to be anticoagulated [see Warnings and Precautions (5.3)].
WARNING: (A) PREMATURE DISCONTINUATION OF ELIQUIS INCREASES THE RISK OF THROMBOTIC EVENTS
(B) SPINAL/EPIDURAL HEMATOMA
See full prescribing information for complete boxed warning.
(A) PREMATURE DISCONTINUATION OF ELIQUIS INCREASES THE RISK OF THROMBOTIC EVENTS: Premature discontinuation of any oral anticoagulant, including ELIQUIS, increases the risk of thrombotic events. To reduce this risk, consider coverage with another anticoagulant if ELIQUIS is discontinued for a reason other than pathological bleeding or completion of a course of therapy. (2.5, 5.1, 14.1)
(B) SPINAL/EPIDURAL HEMATOMA: Epidural or spinal hematomas may occur in patients treated with ELIQUIS who are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures. (5.3)
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA202155 · Bristol Myers Squibb
- First approved
- December 28, 2012 (14 years ago)
- Latest approved change
- June 24, 2026
- Approved label
- PDF, Jun 29, 2026
- Generic makers
- None on the market
- Last patent listed
- August 24, 2031
- Exclusivity ends
- October 17, 2028
Patent dates are what the maker lists with FDA. Generic launch dates are often set by court rulings or settlements instead. Upcoming generics.
Eliquis questions
How much does eliquis cost without insurance?
Pharmacies pay about $165.64 for 30 tablets of eliquis 5 mg tablet ($5.52 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $200.99. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is there a generic for Eliquis?
Yes: apixaban. Compare apixaban prices.
Is eliquis in shortage?
No shortage is reported for eliquis right now. We check the national shortage list every day.
Has eliquis been recalled?
1 recall on record, none ongoing. Recalls name specific lots - check yours.
When did the eliquis label last change?
The official label was last updated on November 12, 2026 (version 39). See what changed.
Does Medicare have a negotiated price for Eliquis?
Yes: $231.00 for a 30-day supply of Eliquis, from January 1, 2026. What you pay still depends on your plan.
Talk about eliquis
No comments yet. Questions, tips, what worked for you - start the conversation.